Fxr Agonists | List of Frontiers open access articles

Review

Published on 26 Aug 2020

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases

in Cardiovascular and Smooth Muscle Pharmacology

Chao Li
Jie Yang
Yu Wang
Yingzi Qi
Wenqing Yang
Yunlun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01247

23,460 views
46 citations

Mini Review

Published on 23 Jun 2023

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension

in Vascular Physiology

John D. Imig

Frontiers in Physiology

doi 10.3389/fphys.2023.1186477

4,116 views
3 citations

Original Research

Published on 27 Jan 2023

Stimulation of the farnesoid X receptor promotes M2 macrophage polarization

in Inflammation

Thiranut Jaroonwitchawan
Hideki Arimochi
Yuki Sasaki
Chieko Ishifune
Hiroyuki Kondo
Kunihiro Otsuka
Shin-ichi Tsukumo
Koji Yasutomo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1065790

6,676 views
27 citations

Original Research

Published on 15 Jun 2023

Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies

in Experimental Pharmacology and Drug Discovery

Lili Xi
Axi Shi
Tiantian Shen
Guoxu Wang
Yuhui Wei
Jingjing Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1197856

3,835 views
3 citations

Review

Published on 05 Jan 2022

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor

in Ethnopharmacology

Jianglian She
Tanwei Gu
Xiaoyan Pang
Yonghong Liu
Lan Tang
Xuefeng Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.772435

16,553 views
38 citations

Review

Published on 06 Oct 2022

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer

in Gastrointestinal and Hepatic Pharmacology

Mengjiao Zhou
Danfeng Wang
Xiang Li
Ying Cao
Chengxue Yi
Dickson Kofi Wiredu Ocansey
Yuling Zhou
Fei Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1016836

12,819 views
40 citations

Articles

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension

Stimulation of the farnesoid X receptor promotes M2 macrophage polarization

Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer